• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 的多组学研究:在临床中发现那些看不见但被忽视的东西。

Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.

机构信息

Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.

Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.

出版信息

Cell Rep Med. 2022 Mar 15;3(3):100580. doi: 10.1016/j.xcrm.2022.100580.

DOI:10.1016/j.xcrm.2022.100580
PMID:35474745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8922556/
Abstract

COVID-19 is an ongoing pandemic of global concern and is unlikely to disappear. This commentary discusses how multi-omics technologies have helped uncover the molecular processes and dynamics underlying COVID-19 initiation, progression, and transmission, and how lack of standardization has limited their application in clinical settings.

摘要

COVID-19 是一场正在进行的全球关注的大流行病,不太可能消失。本评论讨论了多组学技术如何帮助揭示 COVID-19 发病、进展和传播的分子过程和动态,以及缺乏标准化如何限制了它们在临床环境中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc2/9040179/d4c60309342e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc2/9040179/e8e32279a02b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc2/9040179/d4c60309342e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc2/9040179/e8e32279a02b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc2/9040179/d4c60309342e/gr2.jpg

相似文献

1
Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic.COVID-19 的多组学研究:在临床中发现那些看不见但被忽视的东西。
Cell Rep Med. 2022 Mar 15;3(3):100580. doi: 10.1016/j.xcrm.2022.100580.
2
Multi-omics for COVID-19: driving development of therapeutics and vaccines.用于 COVID-19 的多组学:推动治疗方法和疫苗的发展。
Natl Sci Rev. 2023 May 30;10(9):nwad161. doi: 10.1093/nsr/nwad161. eCollection 2023 Sep.
3
The Need for Multi-Omics Biomarker Signatures in Precision Medicine.精准医学中多组学生物标志物特征的必要性。
Int J Mol Sci. 2019 Sep 26;20(19):4781. doi: 10.3390/ijms20194781.
4
"Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.制药研究中的“组学”:概述、应用、挑战及未来展望。
Chin J Nat Med. 2015 Jan;13(1):3-21. doi: 10.1016/S1875-5364(15)60002-4.
5
Omics for the future in asthma.哮喘领域未来的组学研究
Semin Immunopathol. 2020 Feb;42(1):111-126. doi: 10.1007/s00281-019-00776-x. Epub 2020 Jan 15.
6
Biomedical omics: first insights of a new MSc degree of the University of Milan.生物医学组学:米兰大学新开设的理学硕士学位课程的初步见解。
Tumori. 2022 Feb;108(1):6-11. doi: 10.1177/03008916211047268. Epub 2021 Sep 29.
7
Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications.人支气管-肺蛋白质组学在 2019 年冠状病毒病(COVID-19)大流行中的应用和意义。
Expert Rev Proteomics. 2021 Nov;18(11):925-938. doi: 10.1080/14789450.2021.2010549. Epub 2021 Dec 19.
8
The future is now? Clinical and translational aspects of "Omics" technologies.未来已来?“组学”技术的临床和转化方面。
Immunol Cell Biol. 2021 Feb;99(2):168-176. doi: 10.1111/imcb.12404. Epub 2020 Oct 12.
9
Application of omics technologies in dermatological research and skin management.组学技术在皮肤科研究和皮肤管理中的应用。
J Cosmet Dermatol. 2022 Feb;21(2):451-460. doi: 10.1111/jocd.14100. Epub 2021 Apr 1.
10
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.COVIDomics:COVID-19 的蛋白质组学和代谢组学特征。
Int J Mol Sci. 2022 Feb 22;23(5):2414. doi: 10.3390/ijms23052414.

引用本文的文献

1
MixOmics Integration of Biological Datasets Identifies Highly Correlated Variables of COVID-19 Severity.生物数据集的MixOmics整合识别出与新冠病毒疾病严重程度高度相关的变量。
Int J Mol Sci. 2025 May 15;26(10):4743. doi: 10.3390/ijms26104743.
2
Proteomic Analysis of 442 Clinical Plasma Samples From Individuals With Symptom Records Revealed Subtypes of Convalescent Patients Who Had COVID-19.对442份有症状记录个体的临床血浆样本进行蛋白质组学分析,揭示了感染过新冠病毒的康复患者的亚型。
J Med Virol. 2025 Apr;97(4):e70203. doi: 10.1002/jmv.70203.
3
Proteomics approaches to long COVID: status and outlooks.

本文引用的文献

1
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.尽管接种了mRNA疫苗加强针,但仍出现了新冠病毒奥密克戎变异株突破性感染。
Lancet. 2022 Feb 12;399(10325):625-626. doi: 10.1016/S0140-6736(22)00090-3. Epub 2022 Jan 18.
2
Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.尿蛋白质组学和代谢组学分析揭示 COVID-19 患者的免疫反应。
Cell Rep. 2022 Jan 18;38(3):110271. doi: 10.1016/j.celrep.2021.110271. Epub 2021 Dec 28.
3
Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data.
长新冠的蛋白质组学研究方法:现状与展望
Life Med. 2023 Jun 19;2(3):lnad023. doi: 10.1093/lifemedi/lnad023. eCollection 2023 Jun.
4
Integrated multi-omics analysis reveals liver metabolic reprogramming by fish iridovirus and antiviral function of alpha-linolenic acid.整合多组学分析揭示鱼类虹彩病毒引起的肝脏代谢重编程和α-亚麻酸的抗病毒功能。
Zool Res. 2024 May 18;45(3):520-534. doi: 10.24272/j.issn.2095-8137.2024.028.
5
Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1.SP1对新型冠状病毒受体ACE2的转录调控
Elife. 2024 Feb 20;13:e85985. doi: 10.7554/eLife.85985.
6
Omics-CNN: A comprehensive pipeline for predictive analytics in quantitative omics using one-dimensional convolutional neural networks.组学卷积神经网络(Omics-CNN):一种使用一维卷积神经网络进行定量组学预测分析的综合流程。
Heliyon. 2023 Oct 28;9(11):e21165. doi: 10.1016/j.heliyon.2023.e21165. eCollection 2023 Nov.
7
Towards precision medicine: Omics approach for COVID-19.迈向精准医学:针对2019冠状病毒病的组学方法。
Biosaf Health. 2023 Apr;5(2):78-88. doi: 10.1016/j.bsheal.2023.01.002. Epub 2023 Jan 18.
8
Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.基于蛋白质组学的 SARS-CoV-2 感染人鼻咽样本的质谱分析。
Mass Spectrom Rev. 2024 Jan-Feb;43(1):193-229. doi: 10.1002/mas.21813. Epub 2022 Sep 29.
基因组流行病学与国际和地区旅行在津巴布韦 SARS-CoV-2 疫情中的作用:基于常规监测数据的回顾性研究。
Lancet Glob Health. 2021 Dec;9(12):e1658-e1666. doi: 10.1016/S2214-109X(21)00434-4. Epub 2021 Oct 22.
4
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.严重 COVID-19 中 SARS-CoV-2 感染局部固有免疫力受损。
Cell. 2021 Sep 2;184(18):4713-4733.e22. doi: 10.1016/j.cell.2021.07.023. Epub 2021 Jul 23.
5
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans.人类接种疫苗预防 COVID-19 的免疫机制。
Nat Rev Immunol. 2021 Aug;21(8):475-484. doi: 10.1038/s41577-021-00578-z. Epub 2021 Jul 1.
6
High-throughput proteomics and AI for cancer biomarker discovery.高通量蛋白质组学和人工智能在癌症生物标志物发现中的应用。
Adv Drug Deliv Rev. 2021 Sep;176:113844. doi: 10.1016/j.addr.2021.113844. Epub 2021 Jun 26.
7
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
8
Multi-organ proteomic landscape of COVID-19 autopsies.COVID-19 尸检的多器官蛋白质组学图谱。
Cell. 2021 Feb 4;184(3):775-791.e14. doi: 10.1016/j.cell.2021.01.004. Epub 2021 Jan 9.
9
False negative rate of COVID-19 PCR testing: a discordant testing analysis.新冠肺炎 PCR 检测的假阴性率:一项不一致的检测分析。
Virol J. 2021 Jan 9;18(1):13. doi: 10.1186/s12985-021-01489-0.
10
Histopathological observations in COVID-19: a systematic review.新型冠状病毒肺炎的组织病理学观察:一项系统综述
J Clin Pathol. 2021 Feb;74(2):76-83. doi: 10.1136/jclinpath-2020-206995. Epub 2020 Aug 18.